| 7,10-Dimethoxy-10-DAB III Basic information |
| Product Name: | 7,10-Dimethoxy-10-DAB III |
| Synonyms: | 7β,10β-diMethoxy-10-deacetylbaccatin III;Cabazitaxel interMediate 1;7,10-MeO-10-DAB;7β,10β-Dimethoxy-10-dabⅢ;7β,10β-diMethoxy-10-DAB-II;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-diMethoxy-4a,8,13,13-tetraMethyl-7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxe;7,1-DiMethoxy-1-DAB III;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-oneChemicalBook |
| CAS: | 183133-94-0 |
| MF: | C31H40O10 |
| MW: | 572.64 |
| EINECS: | 1592732-453-0 |
| Product Categories: | API;Intermediates;183133-94-0 |
| Mol File: | 183133-94-0.mol |
| 7,10-Dimethoxy-10-DAB III Chemical Properties |
| Melting point | >225°C (dec.) |
| Boiling point | 675.8±55.0 °C(Predicted) |
| density | 1.31 |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | DMF (Slightly, Heated, Sonicated), DMSO (Very Slightly, Heated), Methanol and Wa |
| form | Solid |
| pka | 12.82±0.70(Predicted) |
| color | White to Off-White |
| Stability: | Hygroscopic |
| Safety Information |
| HS Code | 29329990 |
| MSDS Information |
| 7,10-Dimethoxy-10-DAB III Usage And Synthesis |
| Description | Cabazitaxel is a kind of Second line Drug for the treatment of prostate cancer, FDA Priority Review status approval listing is obtained because its curative effect is remarkable, for the advanced prostate cancer patients to the invalid even aggravation of Docetaxel, the first-selected medicine being used for the treatment of late period, hormone antagonist type prostate cancer.7,10-dimethoxy-10-Dab III is the important intermediate preparing Cabazitaxel. |
| Uses | 4-Deacetyl-4-propionyl Cabazitaxel is an impurity of Cabazitaxel (C046500).A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor. |
| Synthesis | Solvent is methylene dichloride, and alkali is the two dimethylamino naphthalene of 1,8-, and the mol ratio of 10-deacetylate Bakating III and trimethylammonium oxygen Tetrafluoroboric acid is 1:35; The mol ratio of 10-deacetylate Bakating III and alkali is 1:45;By 10-Dab (10g, 18.4mmol) be dissolved in methylene dichloride (200ml), add 1, the two dimethylamino naphthalene (177.2g of 8-, 828mmol), stirring at room temperature half an hour, add trimethylammonium oxygen Tetrafluoroboric acid (95.2g, 643.4mmol) again, stirring at room temperature 20h, suction filtration reaction solution, filter cake methylene dichloride washes 3 times, collects filtrate, and after concentrated, column chromatography (chloroform: methyl alcohol=100:3) obtains 7,10-dimethoxy-10Dab III 4.6g, yield 43.7%. |
| 7,10-Dimethoxy-10-DAB III Preparation Products And Raw materials |
| Raw materials | Sulfurous acid, methyl trifluoromethyl ester-->Cabazitaxel Impurity DJ-->10-Deacetylbaccatin III-->Methyl trifluoromethanesulfonate-->Dimethyl sulfate-->Iodomethane-->Dimethyl carbonate |
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye